Korro Bio to Participate in 2022 Jefferies Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Korro Bio, Inc., a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced that Ram Aiyar, Ph.D., MBA, Chief Executive Officer, will present at the 2022 Jefferies Healthcare Conference, being held in New York, NY, on Thursday, June 9, 2022, at 10:30 a.m. EDT. About Korro … [Read more…]